The therapeutic importance of home blood pressure assessment and combination antihypertensive therapy for achieving target blood pressure control: Ibaraki hypertension ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2010-10-07

AUTHORS

Akira Sato, Shigeyuki Watanabe, Shinji Okubo, Toru Toi, Toshiki Doi, Hideaki Nakano, Junichi Tada, Kazutaka Aonuma,

ABSTRACT

Tight blood pressure (BP) control is important for the prevention of cardiovascular disease in hypertensive patients. A cross-sectional study of 2339 patients from 101 clinics and hospitals in Ibaraki Prefecture was performed to evaluate BP control with the patients’ current antihypertensive medication. Group A (n=892) included high-risk hypertensive patients with at least one of the following risk factors: diabetes mellitus, chronic kidney disease or a history of myocardial infarction. Group B (n=586) included patients <65 years old and Group C (n=859) included patients ⩾65 years old. Both groups B and C included hypertensive patients without the above risk factors. A mean of 1.8±1.0 antihypertensive drugs per patient were prescribed. A total of 35.8% of all patients received monotherapy, 40% received a combination of three therapies and 20.3% received more than three kinds of drugs. The percentage of patients achieving the target BP at the office and at home was significantly higher in Group C than in the other groups (P<0.001). A combination of more than two antihypertensive drugs, including a high dose of either an angiotensin receptor blocker or a calcium channel blocker, was frequently prescribed to Group A to achieve the target office BP. Although the target BP should be lower in Group A (given their comorbidities), the absolute BP value and the number of medications were similar to the other groups. In conclusion, we demonstrated that physicians should treat hypertension more intensively with a combination of more than two antihypertensive drugs, using a high dose to achieve the target BP. In addition, it is important to teach hypertensive patients the clinical importance of monitoring their BP at home and the need to achieve home BP targets. More... »

PAGES

1264-1271

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/hr.2010.175

DOI

http://dx.doi.org/10.1038/hr.2010.175

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1020940475

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/20927115


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Analysis of Variance", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Angiotensin Receptor Antagonists", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antihypertensive Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Pressure", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Pressure Monitoring, Ambulatory", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Calcium Channel Blockers", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chi-Square Distribution", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cross-Sectional Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diabetes Mellitus", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Therapy, Combination", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hypertension", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kidney Failure, Chronic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Myocardial Infarction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Cardiovascular Division, Institute of Clinical Medicine, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan", 
          "id": "http://www.grid.ac/institutes/grid.20515.33", 
          "name": [
            "Cardiovascular Division, Institute of Clinical Medicine, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sato", 
        "givenName": "Akira", 
        "id": "sg:person.0717074353.90", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0717074353.90"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cardiovascular Division, Institute of Clinical Medicine, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan", 
          "id": "http://www.grid.ac/institutes/grid.20515.33", 
          "name": [
            "Cardiovascular Division, Institute of Clinical Medicine, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Watanabe", 
        "givenName": "Shigeyuki", 
        "id": "sg:person.010761026067.71", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010761026067.71"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Tokyo Medical University Ibaraki Medical Center, Ibaraki, Japan", 
          "id": "http://www.grid.ac/institutes/grid.412784.c", 
          "name": [
            "Department of Cardiology, Tokyo Medical University Ibaraki Medical Center, Ibaraki, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Okubo", 
        "givenName": "Shinji", 
        "id": "sg:person.0722721254.30", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0722721254.30"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Yuai Memorial Hospital, Ibaraki, Japan", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Cardiology, Yuai Memorial Hospital, Ibaraki, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Toi", 
        "givenName": "Toru", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Sakuradai Doi Clinic, Ibaraki, Japan", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Sakuradai Doi Clinic, Ibaraki, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Doi", 
        "givenName": "Toshiki", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Nakano Heart Clinic, Ibaraki, Japan", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Nakano Heart Clinic, Ibaraki, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nakano", 
        "givenName": "Hideaki", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Kinunomachi Clinic, Ibaraki, Japan", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Kinunomachi Clinic, Ibaraki, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tada", 
        "givenName": "Junichi", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cardiovascular Division, Institute of Clinical Medicine, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan", 
          "id": "http://www.grid.ac/institutes/grid.20515.33", 
          "name": [
            "Cardiovascular Division, Institute of Clinical Medicine, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Aonuma", 
        "givenName": "Kazutaka", 
        "id": "sg:person.0633316506.46", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0633316506.46"
        ], 
        "type": "Person"
      }, 
      {}
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1291/hypres.29.143", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026903818", 
          "https://doi.org/10.1291/hypres.29.143"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/jhh.2009.76", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008082536", 
          "https://doi.org/10.1038/jhh.2009.76"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1291/hypres.31.1595", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029899923", 
          "https://doi.org/10.1291/hypres.31.1595"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.jhh.1001602", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002649795", 
          "https://doi.org/10.1038/sj.jhh.1001602"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11906-996-0005-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023979283", 
          "https://doi.org/10.1007/s11906-996-0005-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/hr.2008.18", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015339541", 
          "https://doi.org/10.1038/hr.2008.18"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/hr.2008.34", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020466738", 
          "https://doi.org/10.1038/hr.2008.34"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2010-10-07", 
    "datePublishedReg": "2010-10-07", 
    "description": "Tight blood pressure (BP) control is important for the prevention of cardiovascular disease in hypertensive patients. A cross-sectional study of 2339 patients from 101 clinics and hospitals in Ibaraki Prefecture was performed to evaluate BP control with the patients\u2019 current antihypertensive medication. Group A (n=892) included high-risk hypertensive patients with at least one of the following risk factors: diabetes mellitus, chronic kidney disease or a history of myocardial infarction. Group B (n=586) included patients <65 years old and Group C (n=859) included patients \u2a7e65 years old. Both groups B and C included hypertensive patients without the above risk factors. A mean of 1.8\u00b11.0 antihypertensive drugs per patient were prescribed. A total of 35.8% of all patients received monotherapy, 40% received a combination of three therapies and 20.3% received more than three kinds of drugs. The percentage of patients achieving the target BP at the office and at home was significantly higher in Group C than in the other groups (P<0.001). A combination of more than two antihypertensive drugs, including a high dose of either an angiotensin receptor blocker or a calcium channel blocker, was frequently prescribed to Group A to achieve the target office BP. Although the target BP should be lower in Group A (given their comorbidities), the absolute BP value and the number of medications were similar to the other groups. In conclusion, we demonstrated that physicians should treat hypertension more intensively with a combination of more than two antihypertensive drugs, using a high dose to achieve the target BP. In addition, it is important to teach hypertensive patients the clinical importance of monitoring their BP at home and the need to achieve home BP targets.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/hr.2010.175", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1313717", 
        "issn": [
          "0916-9636", 
          "1348-4214"
        ], 
        "name": "Hypertension Research", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "12", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "33"
      }
    ], 
    "keywords": [
      "current antihypertensive medication", 
      "blood pressure control", 
      "hypertensive patients", 
      "target BP", 
      "antihypertensive drugs", 
      "group A", 
      "risk factors", 
      "group B", 
      "high dose", 
      "group C", 
      "pressure control", 
      "high-risk hypertensive patients", 
      "target blood pressure control", 
      "tight blood pressure control", 
      "target office BP", 
      "absolute BP values", 
      "combination antihypertensive therapy", 
      "above risk factors", 
      "percentage of patients", 
      "angiotensin receptor blockers", 
      "chronic kidney disease", 
      "number of medications", 
      "calcium channel blockers", 
      "blood pressure assessment", 
      "cross-sectional study", 
      "BP control", 
      "antihypertensive medication", 
      "office BP", 
      "antihypertensive therapy", 
      "receptor blockers", 
      "diabetes mellitus", 
      "BP targets", 
      "kidney disease", 
      "myocardial infarction", 
      "kinds of drugs", 
      "BP values", 
      "cardiovascular disease", 
      "channel blockers", 
      "patients", 
      "clinical importance", 
      "pressure assessment", 
      "therapeutic importance", 
      "drugs", 
      "medications", 
      "blockers", 
      "assessment trials", 
      "therapy", 
      "disease", 
      "dose", 
      "monotherapy", 
      "mellitus", 
      "hypertension", 
      "infarction", 
      "group", 
      "clinic", 
      "hospital", 
      "years", 
      "physicians", 
      "control", 
      "trials", 
      "prevention", 
      "home", 
      "factors", 
      "total", 
      "conclusion", 
      "combination", 
      "percentage", 
      "assessment", 
      "BP", 
      "target", 
      "history", 
      "study", 
      "importance", 
      "need", 
      "Ibaraki Prefecture", 
      "addition", 
      "number", 
      "office", 
      "Prefecture", 
      "values", 
      "means", 
      "kind", 
      "patients\u2019 current antihypertensive medication", 
      "home BP targets", 
      "home blood pressure assessment", 
      "Ibaraki hypertension assessment trial", 
      "hypertension assessment trial"
    ], 
    "name": "The therapeutic importance of home blood pressure assessment and combination antihypertensive therapy for achieving target blood pressure control: Ibaraki hypertension assessment trial", 
    "pagination": "1264-1271", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1020940475"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/hr.2010.175"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "20927115"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/hr.2010.175", 
      "https://app.dimensions.ai/details/publication/pub.1020940475"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:23", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_509.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/hr.2010.175"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/hr.2010.175'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/hr.2010.175'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/hr.2010.175'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/hr.2010.175'


 

This table displays all metadata directly associated to this object as RDF triples.

320 TRIPLES      22 PREDICATES      141 URIs      126 LITERALS      28 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/hr.2010.175 schema:about N02b06f8736b447fd8ff4a4d2ba8a8d9d
2 N1c3af0908dcb47918b4243ea3c1173cf
3 N3c12d60ad2484a38b0717082889d3760
4 N4cb061ec4f044b84af6e98400de38753
5 N501e0d4b4b0542b080c2ebac8075bc65
6 N5277884704b7437cb2bfcd6656e3a569
7 N545f3c243b704de099ed5f2def2731d3
8 N5e25ed4125564f95a18998f5c9c4fd83
9 N602143aedae34ce99fa9b9386e29ed50
10 N6a8fa12f5d674240a44cc94b5ee37300
11 N7cb8912e56664c8cba7a5357b176dcf3
12 N87184959795543a88ff1f66240971ed9
13 N8cb443b457b547788a73101eb8d459f3
14 Naea62070ac9f4d649a3948bd697fa307
15 Nb2a6cb58d9d64db79e2da59cc495ec69
16 Nb43c093308ef4b57afe08a62d631a5fb
17 Nd0c3c60194554d729d6ef91a149325ce
18 Nd0efbbdb91d84bb19f531646f4fce0a5
19 Neacc1d48a3b74d50b9f97944e73b11d8
20 Nf214164412ab4f71a91881d6896b2250
21 Nf26e8f9380a54446a7f5ae48855a00d9
22 anzsrc-for:11
23 anzsrc-for:1102
24 schema:author Ndd6d50ea1b4641648f774e2236aa9374
25 schema:citation sg:pub.10.1007/s11906-996-0005-z
26 sg:pub.10.1038/hr.2008.18
27 sg:pub.10.1038/hr.2008.34
28 sg:pub.10.1038/jhh.2009.76
29 sg:pub.10.1038/sj.jhh.1001602
30 sg:pub.10.1291/hypres.29.143
31 sg:pub.10.1291/hypres.31.1595
32 schema:datePublished 2010-10-07
33 schema:datePublishedReg 2010-10-07
34 schema:description Tight blood pressure (BP) control is important for the prevention of cardiovascular disease in hypertensive patients. A cross-sectional study of 2339 patients from 101 clinics and hospitals in Ibaraki Prefecture was performed to evaluate BP control with the patients’ current antihypertensive medication. Group A (n=892) included high-risk hypertensive patients with at least one of the following risk factors: diabetes mellitus, chronic kidney disease or a history of myocardial infarction. Group B (n=586) included patients <65 years old and Group C (n=859) included patients ⩾65 years old. Both groups B and C included hypertensive patients without the above risk factors. A mean of 1.8±1.0 antihypertensive drugs per patient were prescribed. A total of 35.8% of all patients received monotherapy, 40% received a combination of three therapies and 20.3% received more than three kinds of drugs. The percentage of patients achieving the target BP at the office and at home was significantly higher in Group C than in the other groups (P<0.001). A combination of more than two antihypertensive drugs, including a high dose of either an angiotensin receptor blocker or a calcium channel blocker, was frequently prescribed to Group A to achieve the target office BP. Although the target BP should be lower in Group A (given their comorbidities), the absolute BP value and the number of medications were similar to the other groups. In conclusion, we demonstrated that physicians should treat hypertension more intensively with a combination of more than two antihypertensive drugs, using a high dose to achieve the target BP. In addition, it is important to teach hypertensive patients the clinical importance of monitoring their BP at home and the need to achieve home BP targets.
35 schema:genre article
36 schema:inLanguage en
37 schema:isAccessibleForFree true
38 schema:isPartOf N6037defcec27427fb149c816ca021b81
39 N61faf84891994a0380f7af69db176563
40 sg:journal.1313717
41 schema:keywords BP
42 BP control
43 BP targets
44 BP values
45 Ibaraki Prefecture
46 Ibaraki hypertension assessment trial
47 Prefecture
48 above risk factors
49 absolute BP values
50 addition
51 angiotensin receptor blockers
52 antihypertensive drugs
53 antihypertensive medication
54 antihypertensive therapy
55 assessment
56 assessment trials
57 blockers
58 blood pressure assessment
59 blood pressure control
60 calcium channel blockers
61 cardiovascular disease
62 channel blockers
63 chronic kidney disease
64 clinic
65 clinical importance
66 combination
67 combination antihypertensive therapy
68 conclusion
69 control
70 cross-sectional study
71 current antihypertensive medication
72 diabetes mellitus
73 disease
74 dose
75 drugs
76 factors
77 group
78 group A
79 group B
80 group C
81 high dose
82 high-risk hypertensive patients
83 history
84 home
85 home BP targets
86 home blood pressure assessment
87 hospital
88 hypertension
89 hypertension assessment trial
90 hypertensive patients
91 importance
92 infarction
93 kidney disease
94 kind
95 kinds of drugs
96 means
97 medications
98 mellitus
99 monotherapy
100 myocardial infarction
101 need
102 number
103 number of medications
104 office
105 office BP
106 patients
107 patients’ current antihypertensive medication
108 percentage
109 percentage of patients
110 physicians
111 pressure assessment
112 pressure control
113 prevention
114 receptor blockers
115 risk factors
116 study
117 target
118 target BP
119 target blood pressure control
120 target office BP
121 therapeutic importance
122 therapy
123 tight blood pressure control
124 total
125 trials
126 values
127 years
128 schema:name The therapeutic importance of home blood pressure assessment and combination antihypertensive therapy for achieving target blood pressure control: Ibaraki hypertension assessment trial
129 schema:pagination 1264-1271
130 schema:productId N6b2ca02b9b84474cb3020b2f8911842e
131 N8a1058303b004b6f98392cad4853eac4
132 Na78ce60f4ff44661a435162207d64e4b
133 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020940475
134 https://doi.org/10.1038/hr.2010.175
135 schema:sdDatePublished 2022-01-01T18:23
136 schema:sdLicense https://scigraph.springernature.com/explorer/license/
137 schema:sdPublisher N83adaf06ed30420788c08708242ddf7d
138 schema:url https://doi.org/10.1038/hr.2010.175
139 sgo:license sg:explorer/license/
140 sgo:sdDataset articles
141 rdf:type schema:ScholarlyArticle
142 N02b06f8736b447fd8ff4a4d2ba8a8d9d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Drug Therapy, Combination
144 rdf:type schema:DefinedTerm
145 N0f8eb5e415f745128295d060b3e8e506 rdf:first Na238d5fbcf0e4cb2ac99c91e6e20f7c7
146 rdf:rest Na06049e2c0a042dd88019a702af37a93
147 N12f05cdf7f1a47429dead90660aaa958 schema:affiliation grid-institutes:None
148 schema:familyName Toi
149 schema:givenName Toru
150 rdf:type schema:Person
151 N177838dbb58d4860a19219432eca5a4e rdf:first sg:person.0722721254.30
152 rdf:rest Na45baf74516c46afb9dfcc5e6be13c4f
153 N1c3af0908dcb47918b4243ea3c1173cf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Blood Pressure Monitoring, Ambulatory
155 rdf:type schema:DefinedTerm
156 N2e56990850e541d3abe0b3cfe5a668e7 rdf:first sg:person.010761026067.71
157 rdf:rest N177838dbb58d4860a19219432eca5a4e
158 N3c12d60ad2484a38b0717082889d3760 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Calcium Channel Blockers
160 rdf:type schema:DefinedTerm
161 N4642929f4ed24799af4562b5f5e79154 schema:affiliation grid-institutes:None
162 schema:familyName Doi
163 schema:givenName Toshiki
164 rdf:type schema:Person
165 N4cb061ec4f044b84af6e98400de38753 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Antihypertensive Agents
167 rdf:type schema:DefinedTerm
168 N501e0d4b4b0542b080c2ebac8075bc65 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Male
170 rdf:type schema:DefinedTerm
171 N5277884704b7437cb2bfcd6656e3a569 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Chi-Square Distribution
173 rdf:type schema:DefinedTerm
174 N545f3c243b704de099ed5f2def2731d3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Kidney Failure, Chronic
176 rdf:type schema:DefinedTerm
177 N5e25ed4125564f95a18998f5c9c4fd83 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
178 schema:name Humans
179 rdf:type schema:DefinedTerm
180 N602143aedae34ce99fa9b9386e29ed50 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
181 schema:name Female
182 rdf:type schema:DefinedTerm
183 N6037defcec27427fb149c816ca021b81 schema:issueNumber 12
184 rdf:type schema:PublicationIssue
185 N61faf84891994a0380f7af69db176563 schema:volumeNumber 33
186 rdf:type schema:PublicationVolume
187 N6a8fa12f5d674240a44cc94b5ee37300 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
188 schema:name Hypertension
189 rdf:type schema:DefinedTerm
190 N6b2ca02b9b84474cb3020b2f8911842e schema:name dimensions_id
191 schema:value pub.1020940475
192 rdf:type schema:PropertyValue
193 N7cb8912e56664c8cba7a5357b176dcf3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
194 schema:name Aged, 80 and over
195 rdf:type schema:DefinedTerm
196 N82ce77f1b0344b129d27d32eb4af66d6 rdf:first sg:person.0633316506.46
197 rdf:rest N84305f32d98c4b2385cc88c44884a43a
198 N83adaf06ed30420788c08708242ddf7d schema:name Springer Nature - SN SciGraph project
199 rdf:type schema:Organization
200 N84305f32d98c4b2385cc88c44884a43a rdf:first Nb9bd59ce0bf14f229b194e3d2f7741ee
201 rdf:rest rdf:nil
202 N87184959795543a88ff1f66240971ed9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
203 schema:name Aged
204 rdf:type schema:DefinedTerm
205 N8a1058303b004b6f98392cad4853eac4 schema:name pubmed_id
206 schema:value 20927115
207 rdf:type schema:PropertyValue
208 N8cb443b457b547788a73101eb8d459f3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
209 schema:name Treatment Outcome
210 rdf:type schema:DefinedTerm
211 Na06049e2c0a042dd88019a702af37a93 rdf:first Ne9144707e7bd4573bbd5794fa51b6d35
212 rdf:rest N82ce77f1b0344b129d27d32eb4af66d6
213 Na238d5fbcf0e4cb2ac99c91e6e20f7c7 schema:affiliation grid-institutes:None
214 schema:familyName Nakano
215 schema:givenName Hideaki
216 rdf:type schema:Person
217 Na45baf74516c46afb9dfcc5e6be13c4f rdf:first N12f05cdf7f1a47429dead90660aaa958
218 rdf:rest Nc97f28c7c55043ec869124ae295f97fe
219 Na78ce60f4ff44661a435162207d64e4b schema:name doi
220 schema:value 10.1038/hr.2010.175
221 rdf:type schema:PropertyValue
222 Naea62070ac9f4d649a3948bd697fa307 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
223 schema:name Cross-Sectional Studies
224 rdf:type schema:DefinedTerm
225 Nb2a6cb58d9d64db79e2da59cc495ec69 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
226 schema:name Blood Pressure
227 rdf:type schema:DefinedTerm
228 Nb43c093308ef4b57afe08a62d631a5fb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
229 schema:name Risk Factors
230 rdf:type schema:DefinedTerm
231 Nc97f28c7c55043ec869124ae295f97fe rdf:first N4642929f4ed24799af4562b5f5e79154
232 rdf:rest N0f8eb5e415f745128295d060b3e8e506
233 Nd0c3c60194554d729d6ef91a149325ce schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
234 schema:name Middle Aged
235 rdf:type schema:DefinedTerm
236 Nd0efbbdb91d84bb19f531646f4fce0a5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
237 schema:name Diabetes Mellitus
238 rdf:type schema:DefinedTerm
239 Ndd6d50ea1b4641648f774e2236aa9374 rdf:first sg:person.0717074353.90
240 rdf:rest N2e56990850e541d3abe0b3cfe5a668e7
241 Ne9144707e7bd4573bbd5794fa51b6d35 schema:affiliation grid-institutes:None
242 schema:familyName Tada
243 schema:givenName Junichi
244 rdf:type schema:Person
245 Neacc1d48a3b74d50b9f97944e73b11d8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
246 schema:name Angiotensin Receptor Antagonists
247 rdf:type schema:DefinedTerm
248 Nf214164412ab4f71a91881d6896b2250 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
249 schema:name Analysis of Variance
250 rdf:type schema:DefinedTerm
251 Nf26e8f9380a54446a7f5ae48855a00d9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
252 schema:name Myocardial Infarction
253 rdf:type schema:DefinedTerm
254 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
255 schema:name Medical and Health Sciences
256 rdf:type schema:DefinedTerm
257 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
258 schema:name Cardiorespiratory Medicine and Haematology
259 rdf:type schema:DefinedTerm
260 sg:journal.1313717 schema:issn 0916-9636
261 1348-4214
262 schema:name Hypertension Research
263 schema:publisher Springer Nature
264 rdf:type schema:Periodical
265 sg:person.010761026067.71 schema:affiliation grid-institutes:grid.20515.33
266 schema:familyName Watanabe
267 schema:givenName Shigeyuki
268 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010761026067.71
269 rdf:type schema:Person
270 sg:person.0633316506.46 schema:affiliation grid-institutes:grid.20515.33
271 schema:familyName Aonuma
272 schema:givenName Kazutaka
273 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0633316506.46
274 rdf:type schema:Person
275 sg:person.0717074353.90 schema:affiliation grid-institutes:grid.20515.33
276 schema:familyName Sato
277 schema:givenName Akira
278 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0717074353.90
279 rdf:type schema:Person
280 sg:person.0722721254.30 schema:affiliation grid-institutes:grid.412784.c
281 schema:familyName Okubo
282 schema:givenName Shinji
283 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0722721254.30
284 rdf:type schema:Person
285 sg:pub.10.1007/s11906-996-0005-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1023979283
286 https://doi.org/10.1007/s11906-996-0005-z
287 rdf:type schema:CreativeWork
288 sg:pub.10.1038/hr.2008.18 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015339541
289 https://doi.org/10.1038/hr.2008.18
290 rdf:type schema:CreativeWork
291 sg:pub.10.1038/hr.2008.34 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020466738
292 https://doi.org/10.1038/hr.2008.34
293 rdf:type schema:CreativeWork
294 sg:pub.10.1038/jhh.2009.76 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008082536
295 https://doi.org/10.1038/jhh.2009.76
296 rdf:type schema:CreativeWork
297 sg:pub.10.1038/sj.jhh.1001602 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002649795
298 https://doi.org/10.1038/sj.jhh.1001602
299 rdf:type schema:CreativeWork
300 sg:pub.10.1291/hypres.29.143 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026903818
301 https://doi.org/10.1291/hypres.29.143
302 rdf:type schema:CreativeWork
303 sg:pub.10.1291/hypres.31.1595 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029899923
304 https://doi.org/10.1291/hypres.31.1595
305 rdf:type schema:CreativeWork
306 grid-institutes:None schema:alternateName Department of Cardiology, Yuai Memorial Hospital, Ibaraki, Japan
307 Kinunomachi Clinic, Ibaraki, Japan
308 Nakano Heart Clinic, Ibaraki, Japan
309 Sakuradai Doi Clinic, Ibaraki, Japan
310 schema:name Department of Cardiology, Yuai Memorial Hospital, Ibaraki, Japan
311 Kinunomachi Clinic, Ibaraki, Japan
312 Nakano Heart Clinic, Ibaraki, Japan
313 Sakuradai Doi Clinic, Ibaraki, Japan
314 rdf:type schema:Organization
315 grid-institutes:grid.20515.33 schema:alternateName Cardiovascular Division, Institute of Clinical Medicine, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan
316 schema:name Cardiovascular Division, Institute of Clinical Medicine, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan
317 rdf:type schema:Organization
318 grid-institutes:grid.412784.c schema:alternateName Department of Cardiology, Tokyo Medical University Ibaraki Medical Center, Ibaraki, Japan
319 schema:name Department of Cardiology, Tokyo Medical University Ibaraki Medical Center, Ibaraki, Japan
320 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...